RESUMEN
Chlorogenic acid (CGA) is a highly abundant bioactive compound in green coffee beans. CGA has protective roles in various cardiovascular diseases, suggesting that it may affect endothelial cells lining the blood vessels. However, cellular mechanisms underlying its beneficial effects remained unclear. We therefore performed quantitative proteomics of CGA-treated human endothelial cells, followed by enrichment/pathway analyses, and functional validation using various assays. EA.hy926 cells were treated with 5 µM CGA for 24-h before nanoLC-LTQ-Orbitrap MS/MS analyses. Comparing with control cells, the CGA-treated cells had 185 differentially expressed proteins. Of these, up-regulations of podocalyxin-1 and lamin A/C were confirmed by immunoblotting. Enrichment analysis revealed that CGA mainly affected RNA-binding proteins involved in protein targeting to membrane and exosomal secretion. KEGG pathway analysis of proteins in RNA metabolic process/gene expression cluster revealed the involvement of Rap1 signaling, PI3K/AKT signaling and spliceosome, suggesting their potential roles in modulating tight junction (TJ) barrier and angiogenesis. Functional validation revealed significant increases in ZO-1 (a TJ-associated protein) expression and transendothelial electrical resistance (TEER) in the CGA-treated cells. Finally, CGA enhanced capillary-like endothelial tube formation and secretion of angiopoietin-2 (an angiogenic factor). These novel findings provide insights into cellular mechanisms underlying the beneficial effects of CGA on cardiovascular system via enhancement of endothelial TJ barrier function and angiogenesis.